Patents by Inventor Kiyoyasu Fukushima

Kiyoyasu Fukushima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING SEVERITY OF PNEUMOCOCCAL PNEUMONIA
    Publication number: 20140377765
    Abstract: Provided is a method that can more objectively and rapidly determine severity of pneumococcal pneumonia using blood of a subject. The method determines severity of pneumococcal pneumonia, the method including determining the severity based on the presence or absence of a pneumococcal antigen in blood collected from a subject and at least one biochemical value selected from a blood C-reactive protein (CRP) level, a white blood cell (WBC) count and a blood urea nitrogen (BUN) level.
    Type: Application
    Filed: March 29, 2013
    Publication date: December 25, 2014
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Kiyoyasu Fukushima, Yumi Tanaka
  • Sialylated Lewis.sup.x epitope, antibodies and diagnosis
    Patent number: 4752569
    Abstract: Detection of sialylated Lewis.sup.x antigen in sera is employed as diagnostic of the presence of cancer. Conveniently, monoclonal antibodies are provided which are shown to be useful in the diagnosis of a neoplastic condition, with a wide variety of different tumors.The hybridoma CSLEX1 was deposited at the A.T.C.C. on June 20, 1984 and given Accession No. HB8580.
    Type: Grant
    Filed: June 21, 1984
    Date of Patent: June 21, 1988
    Assignee: The Regents of the University of California
    Inventors: Paul I. Terasaki, Masaki Hirota, Kiyoyasu Fukushima, Akemi Wakisaka, Takashi Iguro